A retrospective study on chemotherapy-induced nausea and vomiting in highly/moderately emetogenic chemotherapy: incidence and prescribing practice

被引：0
|
作者：
Nurul Suhaida Badarudin
Noraida Mohamed Shah
Kamarun Neasa Begam Mohd Kassim
Fuad Ismail
Farida Islahudin
Nurul Ain Mohd Tahir
Suhana Yusak
机构：
[1] Universiti Kebangsaan Malaysia,Centre of Quality Management of Medicines, Faculty of Pharmacy
[2] Kuala Lumpur Campus,Department of Radiotherapy & Oncology
[3] Jalan Raja Muda Abdul Aziz,undefined
[4] National Cancer Institute,undefined
[5] Ministry of Health Malaysia,undefined
[6] Universiti Kebangsaan Malaysia Medical Centre,undefined
来源：
Supportive Care in Cancer | 2022年 / 30卷
关键词：
Chemotherapy-induced nausea vomiting; CINV; CINV incidence; Antiemetic; CINV prophylaxis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5339 / 5349
页数：10
相关论文
共 50 条
  • [31] Antiemetic use and chemotherapy induced nausea and vomiting related hospitalization costs after highly or moderately emetogenic chemotherapy
    Nelson, Winnie W.
    Vaidya, Varun
    Scott, Jeffery A.
    Wang, Brandon
    Lambert, Hunter
    Holmes, Benjamin
    Bailey, William L.
    FUTURE ONCOLOGY, 2023, 19 (01) : 29 - 36
  • [32] A prospective study of palonosetron for prevention of chemotherapy-induced nausea and vomiting in malignant lymphoma patients following highly emetogenic chemotherapy
    Takahashi, Tsutomu
    Okada, Takahiro
    Ikejiri, Fumiyoshi
    Ito, Shunsuke
    Okada, Yusuke
    Takahashi, Fumimasa
    Kumanomido, Satoshi
    Jo, Yumi
    Adachi, Koji
    Onishi, Chie
    Kawakami, Koshi
    Miyake, Takaaki
    Inoue, Masaya
    Suzuki, Ritsuro
    Suzumiya, Junji
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (01) : 189 - 194
  • [33] A prospective study of palonosetron for prevention of chemotherapy-induced nausea and vomiting in malignant lymphoma patients following highly emetogenic chemotherapy
    Tsutomu Takahashi
    Takahiro Okada
    Fumiyoshi Ikejiri
    Shunsuke Ito
    Yusuke Okada
    Fumimasa Takahashi
    Satoshi Kumanomido
    Yumi Jo
    Koji Adachi
    Chie Onishi
    Koshi Kawakami
    Takaaki Miyake
    Masaya Inoue
    Ritsuro Suzuki
    Junji Suzumiya
    International Journal of Clinical Oncology, 2018, 23 : 189 - 194
  • [34] Incidence of chemotherapy-induced nausea and vomiting in 2008
    Martin, I.
    Montheil, V.
    Ropert, S.
    Alexandre, J.
    Goldwasser, F.
    Durand, J. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [35] Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy
    Warr, DG
    Hesketh, PJ
    Gralla, RJ
    Muss, HB
    Herrstedt, J
    Eisenberg, PD
    Raftopoulos, H
    Grunberg, SM
    Gabriel, M
    Rodgers, A
    Bohidar, N
    Klinger, G
    Hustad, CM
    Horgan, KJ
    Skobieranda, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) : 2822 - 2830
  • [36] Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) Associated with Moderately Emetogenic (MEC) Chemotherapy in Patients with Breast Cancer
    Webb, T.
    Hardwick, J.
    Carides, A. D.
    Street, J. C.
    CANCER RESEARCH, 2009, 69 (24) : 575S - 576S
  • [37] Palonosetron Prevents Highly Emetogenic Chemotherapy-induced Nausea and Vomiting in Oral Cancer Patients
    Sento, Shinya
    Kitamura, Naoya
    Yamamoto, Tetsuya
    Nakashiro, Koichi
    Hamakawa, Hiroyuki
    Ibaragi, Soichiro
    Sasaki, Akira
    Takamaru, Natsumi
    Miyamoto, Yoji
    Kodani, Isamu
    Ryoke, Kazuo
    Mishima, Katsuaki
    Ueyama, Yoshiya
    ANTICANCER RESEARCH, 2017, 37 (12) : 6977 - 6981
  • [38] The efficacy of aprepitant in salvage treatment of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy for patients with gastrointestinal cancer
    Qiaoyan Gong
    Jiangfang Tian
    Yulian Jiang
    Xiaofen Li
    Lingyan Zhou
    Dan Cao
    International Journal of Clinical Oncology, 2021, 26 : 1091 - 1098
  • [39] The efficacy of aprepitant in salvage treatment of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy for patients with gastrointestinal cancer
    Gong, Qiaoyan
    Tian, Jiangfang
    Jiang, Yulian
    Li, Xiaofen
    Zhou, Lingyan
    Cao, Dan
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (06) : 1091 - 1098
  • [40] Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of highly or moderately emetogenic chemotherapy (HEC, MEC).
    Rapoport, Bernardo Leon
    Schwartzberg, Lee Steven
    Chasen, Martin Robert
    Powers, Daniel
    Arora, Sujata
    Navari, Rudolph M.
    Schnadig, Ian D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)
12345